Table 9.
Summary of in vivo studies of proapoptotic activity of PCA.
Model | Method | PCA dose/route/duration | Major finding | Interpretation | Reference |
---|---|---|---|---|---|
Rat | NMBA-induced esophageal cancer in rats | PCA 0.05% in diet for 15, 25, and 35 weeks | (i) PCA reduced area of hyperplasia began at week 25 (ii) PCA reduced COX-2, iNOS, soluble epoxide hydrolase (she), and pentraxin-3 (PTX3) mRNA expression levels |
PCA prevented esophageal tumorigenesis, by inhibitory effects on genes associated with inflammation | [59] |